Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
17.71
+0.27 (1.55%)
Sep 17, 2025, 4:00 PM EDT - Market closed
Neurogene Market Cap
Neurogene has a market cap or net worth of $252.76 million as of September 18, 2025. Its market cap has decreased by -48.01% in one year.
Market Cap
252.76M
Enterprise Value
-10.80M
1-Year Change
-48.01%
Ranking
Category
Stock Price
$17.71
Market Cap Chart
Since March 7, 2014, Neurogene's market cap has increased from $114.10M to $252.76M, an increase of 121.52%. That is a compound annual growth rate of 7.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 252.80M | -25.56% |
| Dec 31, 2024 | 339.60M | 646.37% |
| Dec 29, 2023 | 45.50M | 109.68% |
| Dec 30, 2022 | 21.70M | -89.39% |
| Dec 31, 2021 | 204.50M | -65.38% |
| Dec 31, 2020 | 590.70M | 25.07% |
| Dec 31, 2019 | 472.30M | 829.72% |
| Dec 31, 2018 | 50.80M | -81.59% |
| Dec 29, 2017 | 275.90M | -28.65% |
| Dec 30, 2016 | 386.70M | 80.03% |
| Dec 31, 2015 | 214.80M | 167.83% |
| Dec 31, 2014 | 80.20M | -29.71% |
| Mar 7, 2014 | 114.10M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.40B |
| Johnson & Johnson | 426.76B |
| AbbVie | 390.07B |
| UnitedHealth Group | 309.39B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 241.43B |
| Novartis AG | 237.64B |
| Abbott Laboratories | 233.52B |